Drug Profile
NSP 6783
Latest Information Update: 07 Nov 2003
Price :
$50
*
At a glance
- Originator Nippon Kayaku; Signal Pharmaceuticals
- Class Small molecules
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peripheral nervous system diseases
Most Recent Events
- 31 Jul 2000 Discontinued - Preclinical for Peripheral nervous system diseases in Japan (unspecified route)
- 31 Jul 2000 Discontinued - Preclinical for Peripheral nervous system diseases in USA (unspecified route)
- 28 Feb 1997 Preclinical development for Peripheral nervous system diseases in Japan (Unknown route)